Synthetic Kratom Comes Under Federal Spotlight
The proliferation of products derived from synthetically concentrated kratom, known as “gas station opioids,” has drawn attention from federal authorities and lawmakers. These products are sourced from the kratom plant.
Image © Alejandra Villa Loarca/Newsday RM via Getty Images
The Drug Enforcement Administration (DEA) indicated increased concerns earlier this year. The agency announced plans to temporarily prohibit products containing concentrations of 7-hydroxymitragynine (7-OH), mitragynine pseudoindoxyl (MGPI), MGM-15, and MGM-16.
The DEA aims to classify these substances under Schedule I of the Controlled Substances Act. This classification will not affect the natural herbal form of kratom, which is commonly available over the counter. Legal status varies across states, with nine states outright banning the herb and more than 30 states implementing varying regulations. In over a dozen states, kratom exists in a legal gray area.
Concentration Levels and Over-the-Counter Sales
Synthetically concentrated extracts such as 7-OH have become accessible over-the-counter in gas stations and tobacco shops since around 2010. These extracts exist only in trace amounts naturally in the plant.
Oliver Grundmann, a clinical professor at the University of Florida, expressed that scheduling these concentrated products is appropriate. Schedule I classification typically indicates a drug has no accepted medical use. Approval from the Food and Drug Administration (FDA) would be necessary to establish a medical application.
“It is adequate to classify [7-OH] as a controlled substance given the current understanding,” Grundmann explained.
Policy Impacts on Healthcare
Pennsylvania authorities confirmed the state’s sixth death from measles as cases rise nationally. A 39-year-old woman with several underlying conditions died following a recent measles diagnosis. The state contends with the highest number of cases in the country.
NewsNation reports new findings involving GLP-1 drugs. Research suggests these drugs may cause changes in adults with moderate-to-severe psoriasis and obesity. Data from Eli Lilly reveal that patients treated with Taltz (ixekizumab) and Zepbound (tirzepatide) notice broader immune and metabolic changes compared to those using Taltz alone.
A study by the University of Liverpool compared British adults drinking water versus diet soft drinks while managing weight. The results indicate little difference between the groups. Researchers monitored nearly 500 overweight or obese adults over two years, revealing minimal variance.
Support and Other Developments
Congress faces pressure to reject funding cuts that impact patient access to hospital and health systems. Cuts would mean longer wait times, reduced services, or closures, affecting 24/7 healthcare that communities rely on. Advocates urge Congress to protect timely hospital care.
Consequently, new developments elsewhere deserve recognition. The Ebola outbreak in Congo has reached 5,000 cases, highlighting the dangers of rapid spread despite response efforts. This surge challenges containment efforts in remote regions.
Further, Virginia’s proposed reproductive health amendment might alter state abortion laws significantly. In Iowa, healthcare issues feature prominently in Senate races, while Missouri hospitals face workforce challenges due to rising turnover rates.
Other notable mentions include a survey showing Americans’ strong trust in science compared to global peers, lower pregnancy risks in women vaccinated against HPV, and concerns regarding aging U.S. doctors affecting patient safety.
Leave a Reply